Barely Significant
← all excerpts

Hypomethylation of VTRNA2-1 promoter predicts adverse outcomes in peripheral artery disease.

Clin Epigenetics · 2026 · PMC13049864 · PMID 41761304

Europe PMCDOI
1
hedged sentence
0.0510
closest p · 1.0× alpha
0.0510
boldest claim

The sentences

showed a trendp = 0.051so close (0.05 < p ≤ 0.1)
Specifically, patients with hypomethylation showed a trend toward more frequent foot amputations (43.9% versus 27.6%; p = 0.051).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.